Nombre del producto:3-methyl-2-[4-(3-methylsulfonylphenyl)phenyl]-5-(trifluoromethyl)quinoxaline

IUPAC Name:2-{3'-methanesulfonyl-[1,1'-biphenyl]-4-yl}-3-methyl-5-(trifluoromethyl)quinoxaline

CAS:1221265-37-7
Fórmula molecular:C23H17F3N2O2S
Pureza:95%+
Número de catálogo:CM745435
Peso molecular:442.46

Unidad de embalaje Stock disponible Precio($) Cantidad

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :1221265-37-7
Fórmula molecular:C23H17F3N2O2S
Punto de fusión:-
Código de sonrisas:CC1=C(N=C2C=CC=C(C2=N1)C(F)(F)F)C1=CC=C(C=C1)C1=CC(=CC=C1)S(C)(=O)=O
Densidad:
Número de catálogo:CM745435
Peso molecular:442.46
Punto de ebullición:
Nº Mdl:MFCD18206803
Almacenamiento:

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.